NCT00128414View on ClinicalTrials.gov

Study of Colchicine to Treat and Prevent Recurrent Pericarditis (First Episode)

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

April 30, 2009

Study Completion Date

October 31, 2010

Conditions
PericarditisRecurrence
Interventions
DRUG

Colchicine (for 6 months)

colchicine 1.0 mg twice daily for the first day followed by a maintenance dose of 0.5 mg twice daily for 1 month in patients ≥70 kg, and halved doses for patients \<70 kg or intolerant to the highest dose.

DRUG

Placebo

Tablets identical in colour, shape, and taste were provided in blister packs.

Trial Locations (5)

10141

Cardiology Department. Maria Vittoria Hospital. ASL3 Torino, Torino

Unknown

Internal Medicine Dpt. Ospedali Riuniti, Bergamo

Department of Cardiology, San Maurizio Regional Hospital, Bolzano

Cardiology Dpt. Ospedale SS Annunziata, Savigliano

Ospedale di Rivoli, Rivoli

All Listed Sponsors
lead

Azienda Sanitaria Locale 3, Torino

OTHER

NCT00128414 - Study of Colchicine to Treat and Prevent Recurrent Pericarditis (First Episode) | Biotech Hunter | Biotech Hunter